Language selection

Search

2018-03-05 - Female - 38 Years old

710078

Adverse reaction report number 710078
Latest AER version number 0
Market authorization holder AER number N/A
Initial received date 2018-03-05
Latest received date 2018-03-05
Age 38 Years
Gender Female
Weight 86 Kilograms
Type of report Spontaneous
Reporter type Pharmacist
Source of report Hospital
Report outcome Not recovered/not resolved
Serious report? Yes

Reason for seriousness

Death
Disability Yes
Cogenital anomaly
Life threateting Yes
Hospitalization Yes
Other medically important

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XR 10MG MIXED SALTS AMPHETAMINECAPSULE, EXTENDED RELEASESuspectOral 1 every 1 Day(s) Disturbance in attention
ADDERALL XR 30MG MIXED SALTS AMPHETAMINECAPSULE, EXTENDED RELEASESuspectOral 1 every 1 Day(s) Disturbance in attention
BUPROPION SRTABLET (EXTENDED-RELEASE)Concomitant
LAMOTRIGINETABLETConcomitant
TYLENOL #3 (ACETAMINOPHEN/CODEINE)TABLETConcomitant
VALACYCLOVIRNOT SPECIFIEDConcomitant

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Ataxia
Blood pressure abnormal
Brain stem infarction
Cerebellar infarction
Cerebrovascular accident
Cognitive disorder
Headache
Heart rate abnormal
Intracranial artery dissection
Nausea
Neck pain
Vascular pseudoaneurysm
White blood cell disorder
Date modified: